Review




Structured Review

Cellscript Inc t7-scribetm standard rna ivt kit
T7 Scribetm Standard Rna Ivt Kit, supplied by Cellscript Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t7-scribetm+standard+rna+ivt+kit/t7+scribe+standard+rna+ivt+kit/pm40539045-86-18-23
Average 90 stars, based on 1 article reviews
t7-scribetm standard rna ivt kit - by Bioz Stars, 2026-10
90/100 stars

Images

Related Articles

In Vitro:

Article Title: Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect
Article Snippet: A 1671-basepair insert, as shown in FIG. 1, was cut from the plasmid backbone with ClaI and then single-stranded RNA (ssRNA) was generated by in vitro transcription of each DNA strand (FIG. 1) in two separate reactions using either a T7-ScribeTM Standard RNA IVT Kit (CELLSCRIPT, INC., Madison, Wis., USA) or an AmpliScribeTM T3 High Yield transcription Kit (epicentre, WI), respectively.

Article Title: An RNA vaccine against adrenomedullin reduces angiogenesis and tumor burden in a syngeneic metastatic melanoma mouse model.
Article Snippet: 2.4 In vitro transcription, capping and characterization The therapeutic mRNA was synthesized by in vitro transcription (IVT) using T7-Scribe Standard RNA IVT Kit (CellScript, Madison, WI, USA) to produce standard/non-modified mRNA.

Article Title: An RNA vaccine against adrenomedullin reduces angiogenesis and tumor burden in a syngeneic metastatic melanoma mouse model
Article Snippet: The therapeutic mRNA was synthesized by in vitro transcription (IVT) using T7-ScribeTM Standard RNA IVT Kit (CellScript, Madison, WI, USA) to produce standard/non-modified mRNA.

Article Title: Methods of assessing nuclease cleavage
Article Snippet: T Cell—Gene 1/Gene 2 S. pyogenes guide RNAs targeting the Gene 1 and Gene 2 loci were generated by in vitro transcription of a PCR product using the T7-ScribeTM Standard RNA IVT Kit (CELLSCRIPT) following the manufacturer's protocol.

Article Title: Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect
Article Snippet: Each sense or antisense ssRNA strand was synthesized separately by in vitro transcription of a linear luc2 DNA template using either 17 RNA polymerase or T3 RNA polymerase, such as with a commercially available INCOGNITOTM T7 Ψ-RNA transcription kit (CELLSCRIPT, INC., Madison, WI, USA) for making GAψC RNA, or a T7-FLASHSCRIBETM transcription kit or a T7-SCRIBETM standard RNA IVT kit for making GAUC RNA (CELLSCRIPT), or similar home-brew kits containing T3 RNA polymerase.

Article Title: Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect
Article Snippet: In some of these embodiments, the one or more in vitro-synthesized ssRNA molecules that exhibit the 5′ cap were synthesized prior to their use for said treating: (i) co-transcriptionally by incorporation of a cap analog (e.g., an anti-reverse cap analog or ARCA) during in vitro transcription of (e.g., using the MESSAGEMAX T7 ARCA-capped message transcription kit or the INCOGNITO T7 ARCA 5′C- and Ψ-RNA transcription kit, CELLSCRIPT, Inc., Madison, Wis., USA); or (ii) post-transcriptionally by incubating in vitro-transcribed ssRNA molecules with a capping enzyme system comprising RNA guanyltransferase under conditions wherein the in vitro-transcribed ssRNA molecules are 5′-capped, including wherein the capping enzyme system results in methylation of the 2′ hydroxyl of the ribose in the 5′ penultimate nucleotide (e.g., using T7 mSCRIPT standard mRNA production system, or using a separate in vitro transcription system, such as the T7-SCRIBE standard RNA IVT kit, the INCOGNITO T7 Ψ-RNA transcription kit, or the INCOGNITO T7 5mC- and Ψ-RNA transcription kit to obtain ssRNA, and the SCRIPTCAP m7G capping system to obtain cap0 RNA (all from CELLSCRIPT, Inc.); in some embodiments, the capping enzyme system further results in methylation of the 2′ hydroxyl of the ribose in the 5′ penultimate nucleotide to generate cap1 RNA, and the method further comprises: incubating with RNA 2′-O-methyltransferase (e.g., using the SCRIPTCAP 2′-O-methyltransferase kit, CELLSCRIPT, Inc.).

Synthesized:

Article Title: Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect
Article Snippet: A 1671-basepair insert, as shown in FIG. 1, was cut from the plasmid backbone with ClaI and then single-stranded RNA (ssRNA) was generated by in vitro transcription of each DNA strand (FIG. 1) in two separate reactions using either a T7-ScribeTM Standard RNA IVT Kit (CELLSCRIPT, INC., Madison, Wis., USA) or an AmpliScribeTM T3 High Yield transcription Kit (epicentre, WI), respectively.

Article Title: An RNA vaccine against adrenomedullin reduces angiogenesis and tumor burden in a syngeneic metastatic melanoma mouse model.
Article Snippet: 2.4 In vitro transcription, capping and characterization The therapeutic mRNA was synthesized by in vitro transcription (IVT) using T7-Scribe Standard RNA IVT Kit (CellScript, Madison, WI, USA) to produce standard/non-modified mRNA.

Article Title: An RNA vaccine against adrenomedullin reduces angiogenesis and tumor burden in a syngeneic metastatic melanoma mouse model
Article Snippet: The therapeutic mRNA was synthesized by in vitro transcription (IVT) using T7-ScribeTM Standard RNA IVT Kit (CellScript, Madison, WI, USA) to produce standard/non-modified mRNA.

Article Title: Methods of assessing nuclease cleavage
Article Snippet: T Cell—Gene 1/Gene 2 S. pyogenes guide RNAs targeting the Gene 1 and Gene 2 loci were generated by in vitro transcription of a PCR product using the T7-ScribeTM Standard RNA IVT Kit (CELLSCRIPT) following the manufacturer's protocol.

Article Title: Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect
Article Snippet: Each sense or antisense ssRNA strand was synthesized separately by in vitro transcription of a linear luc2 DNA template using either 17 RNA polymerase or T3 RNA polymerase, such as with a commercially available INCOGNITOTM T7 Ψ-RNA transcription kit (CELLSCRIPT, INC., Madison, WI, USA) for making GAψC RNA, or a T7-FLASHSCRIBETM transcription kit or a T7-SCRIBETM standard RNA IVT kit for making GAUC RNA (CELLSCRIPT), or similar home-brew kits containing T3 RNA polymerase.

Article Title: Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect
Article Snippet: In some of these embodiments, the one or more in vitro-synthesized ssRNA molecules that exhibit the 5′ cap were synthesized prior to their use for said treating: (i) co-transcriptionally by incorporation of a cap analog (e.g., an anti-reverse cap analog or ARCA) during in vitro transcription of (e.g., using the MESSAGEMAX T7 ARCA-capped message transcription kit or the INCOGNITO T7 ARCA 5′C- and Ψ-RNA transcription kit, CELLSCRIPT, Inc., Madison, Wis., USA); or (ii) post-transcriptionally by incubating in vitro-transcribed ssRNA molecules with a capping enzyme system comprising RNA guanyltransferase under conditions wherein the in vitro-transcribed ssRNA molecules are 5′-capped, including wherein the capping enzyme system results in methylation of the 2′ hydroxyl of the ribose in the 5′ penultimate nucleotide (e.g., using T7 mSCRIPT standard mRNA production system, or using a separate in vitro transcription system, such as the T7-SCRIBE standard RNA IVT kit, the INCOGNITO T7 Ψ-RNA transcription kit, or the INCOGNITO T7 5mC- and Ψ-RNA transcription kit to obtain ssRNA, and the SCRIPTCAP m7G capping system to obtain cap0 RNA (all from CELLSCRIPT, Inc.); in some embodiments, the capping enzyme system further results in methylation of the 2′ hydroxyl of the ribose in the 5′ penultimate nucleotide to generate cap1 RNA, and the method further comprises: incubating with RNA 2′-O-methyltransferase (e.g., using the SCRIPTCAP 2′-O-methyltransferase kit, CELLSCRIPT, Inc.).

Generated:

Article Title: Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect
Article Snippet: A 1671-basepair insert, as shown in FIG. 1, was cut from the plasmid backbone with ClaI and then single-stranded RNA (ssRNA) was generated by in vitro transcription of each DNA strand (FIG. 1) in two separate reactions using either a T7-ScribeTM Standard RNA IVT Kit (CELLSCRIPT, INC., Madison, Wis., USA) or an AmpliScribeTM T3 High Yield transcription Kit (epicentre, WI), respectively.

Article Title: An RNA vaccine against adrenomedullin reduces angiogenesis and tumor burden in a syngeneic metastatic melanoma mouse model.
Article Snippet: 2.4 In vitro transcription, capping and characterization The therapeutic mRNA was synthesized by in vitro transcription (IVT) using T7-Scribe Standard RNA IVT Kit (CellScript, Madison, WI, USA) to produce standard/non-modified mRNA.

Article Title: An RNA vaccine against adrenomedullin reduces angiogenesis and tumor burden in a syngeneic metastatic melanoma mouse model
Article Snippet: The therapeutic mRNA was synthesized by in vitro transcription (IVT) using T7-ScribeTM Standard RNA IVT Kit (CellScript, Madison, WI, USA) to produce standard/non-modified mRNA.

Article Title: Methods of assessing nuclease cleavage
Article Snippet: T Cell—Gene 1/Gene 2 S. pyogenes guide RNAs targeting the Gene 1 and Gene 2 loci were generated by in vitro transcription of a PCR product using the T7-ScribeTM Standard RNA IVT Kit (CELLSCRIPT) following the manufacturer's protocol.

Article Title: Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect
Article Snippet: Each sense or antisense ssRNA strand was synthesized separately by in vitro transcription of a linear luc2 DNA template using either 17 RNA polymerase or T3 RNA polymerase, such as with a commercially available INCOGNITOTM T7 Ψ-RNA transcription kit (CELLSCRIPT, INC., Madison, WI, USA) for making GAψC RNA, or a T7-FLASHSCRIBETM transcription kit or a T7-SCRIBETM standard RNA IVT kit for making GAUC RNA (CELLSCRIPT), or similar home-brew kits containing T3 RNA polymerase.

Article Title: Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect
Article Snippet: In some of these embodiments, the one or more in vitro-synthesized ssRNA molecules that exhibit the 5′ cap were synthesized prior to their use for said treating: (i) co-transcriptionally by incorporation of a cap analog (e.g., an anti-reverse cap analog or ARCA) during in vitro transcription of (e.g., using the MESSAGEMAX T7 ARCA-capped message transcription kit or the INCOGNITO T7 ARCA 5′C- and Ψ-RNA transcription kit, CELLSCRIPT, Inc., Madison, Wis., USA); or (ii) post-transcriptionally by incubating in vitro-transcribed ssRNA molecules with a capping enzyme system comprising RNA guanyltransferase under conditions wherein the in vitro-transcribed ssRNA molecules are 5′-capped, including wherein the capping enzyme system results in methylation of the 2′ hydroxyl of the ribose in the 5′ penultimate nucleotide (e.g., using T7 mSCRIPT standard mRNA production system, or using a separate in vitro transcription system, such as the T7-SCRIBE standard RNA IVT kit, the INCOGNITO T7 Ψ-RNA transcription kit, or the INCOGNITO T7 5mC- and Ψ-RNA transcription kit to obtain ssRNA, and the SCRIPTCAP m7G capping system to obtain cap0 RNA (all from CELLSCRIPT, Inc.); in some embodiments, the capping enzyme system further results in methylation of the 2′ hydroxyl of the ribose in the 5′ penultimate nucleotide to generate cap1 RNA, and the method further comprises: incubating with RNA 2′-O-methyltransferase (e.g., using the SCRIPTCAP 2′-O-methyltransferase kit, CELLSCRIPT, Inc.).

Polymerase Chain Reaction:

Article Title: Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect
Article Snippet: A 1671-basepair insert, as shown in FIG. 1, was cut from the plasmid backbone with ClaI and then single-stranded RNA (ssRNA) was generated by in vitro transcription of each DNA strand (FIG. 1) in two separate reactions using either a T7-ScribeTM Standard RNA IVT Kit (CELLSCRIPT, INC., Madison, Wis., USA) or an AmpliScribeTM T3 High Yield transcription Kit (epicentre, WI), respectively.

Article Title: An RNA vaccine against adrenomedullin reduces angiogenesis and tumor burden in a syngeneic metastatic melanoma mouse model.
Article Snippet: 2.4 In vitro transcription, capping and characterization The therapeutic mRNA was synthesized by in vitro transcription (IVT) using T7-Scribe Standard RNA IVT Kit (CellScript, Madison, WI, USA) to produce standard/non-modified mRNA.

Article Title: An RNA vaccine against adrenomedullin reduces angiogenesis and tumor burden in a syngeneic metastatic melanoma mouse model
Article Snippet: The therapeutic mRNA was synthesized by in vitro transcription (IVT) using T7-ScribeTM Standard RNA IVT Kit (CellScript, Madison, WI, USA) to produce standard/non-modified mRNA.

Article Title: Methods of assessing nuclease cleavage
Article Snippet: T Cell—Gene 1/Gene 2 S. pyogenes guide RNAs targeting the Gene 1 and Gene 2 loci were generated by in vitro transcription of a PCR product using the T7-ScribeTM Standard RNA IVT Kit (CELLSCRIPT) following the manufacturer's protocol.

Article Title: Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect
Article Snippet: Each sense or antisense ssRNA strand was synthesized separately by in vitro transcription of a linear luc2 DNA template using either 17 RNA polymerase or T3 RNA polymerase, such as with a commercially available INCOGNITOTM T7 Ψ-RNA transcription kit (CELLSCRIPT, INC., Madison, WI, USA) for making GAψC RNA, or a T7-FLASHSCRIBETM transcription kit or a T7-SCRIBETM standard RNA IVT kit for making GAUC RNA (CELLSCRIPT), or similar home-brew kits containing T3 RNA polymerase.

Article Title: Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect
Article Snippet: In some of these embodiments, the one or more in vitro-synthesized ssRNA molecules that exhibit the 5′ cap were synthesized prior to their use for said treating: (i) co-transcriptionally by incorporation of a cap analog (e.g., an anti-reverse cap analog or ARCA) during in vitro transcription of (e.g., using the MESSAGEMAX T7 ARCA-capped message transcription kit or the INCOGNITO T7 ARCA 5′C- and Ψ-RNA transcription kit, CELLSCRIPT, Inc., Madison, Wis., USA); or (ii) post-transcriptionally by incubating in vitro-transcribed ssRNA molecules with a capping enzyme system comprising RNA guanyltransferase under conditions wherein the in vitro-transcribed ssRNA molecules are 5′-capped, including wherein the capping enzyme system results in methylation of the 2′ hydroxyl of the ribose in the 5′ penultimate nucleotide (e.g., using T7 mSCRIPT standard mRNA production system, or using a separate in vitro transcription system, such as the T7-SCRIBE standard RNA IVT kit, the INCOGNITO T7 Ψ-RNA transcription kit, or the INCOGNITO T7 5mC- and Ψ-RNA transcription kit to obtain ssRNA, and the SCRIPTCAP m7G capping system to obtain cap0 RNA (all from CELLSCRIPT, Inc.); in some embodiments, the capping enzyme system further results in methylation of the 2′ hydroxyl of the ribose in the 5′ penultimate nucleotide to generate cap1 RNA, and the method further comprises: incubating with RNA 2′-O-methyltransferase (e.g., using the SCRIPTCAP 2′-O-methyltransferase kit, CELLSCRIPT, Inc.).

Plasmid Preparation:

Article Title: Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect
Article Snippet: A 1671-basepair insert, as shown in FIG. 1, was cut from the plasmid backbone with ClaI and then single-stranded RNA (ssRNA) was generated by in vitro transcription of each DNA strand (FIG. 1) in two separate reactions using either a T7-ScribeTM Standard RNA IVT Kit (CELLSCRIPT, INC., Madison, Wis., USA) or an AmpliScribeTM T3 High Yield transcription Kit (epicentre, WI), respectively.

Article Title: An RNA vaccine against adrenomedullin reduces angiogenesis and tumor burden in a syngeneic metastatic melanoma mouse model.
Article Snippet: 2.4 In vitro transcription, capping and characterization The therapeutic mRNA was synthesized by in vitro transcription (IVT) using T7-Scribe Standard RNA IVT Kit (CellScript, Madison, WI, USA) to produce standard/non-modified mRNA.

Article Title: An RNA vaccine against adrenomedullin reduces angiogenesis and tumor burden in a syngeneic metastatic melanoma mouse model
Article Snippet: The therapeutic mRNA was synthesized by in vitro transcription (IVT) using T7-ScribeTM Standard RNA IVT Kit (CellScript, Madison, WI, USA) to produce standard/non-modified mRNA.

Article Title: Methods of assessing nuclease cleavage
Article Snippet: T Cell—Gene 1/Gene 2 S. pyogenes guide RNAs targeting the Gene 1 and Gene 2 loci were generated by in vitro transcription of a PCR product using the T7-ScribeTM Standard RNA IVT Kit (CELLSCRIPT) following the manufacturer's protocol.

Article Title: Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect
Article Snippet: Each sense or antisense ssRNA strand was synthesized separately by in vitro transcription of a linear luc2 DNA template using either 17 RNA polymerase or T3 RNA polymerase, such as with a commercially available INCOGNITOTM T7 Ψ-RNA transcription kit (CELLSCRIPT, INC., Madison, WI, USA) for making GAψC RNA, or a T7-FLASHSCRIBETM transcription kit or a T7-SCRIBETM standard RNA IVT kit for making GAUC RNA (CELLSCRIPT), or similar home-brew kits containing T3 RNA polymerase.

Article Title: Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect
Article Snippet: In some of these embodiments, the one or more in vitro-synthesized ssRNA molecules that exhibit the 5′ cap were synthesized prior to their use for said treating: (i) co-transcriptionally by incorporation of a cap analog (e.g., an anti-reverse cap analog or ARCA) during in vitro transcription of (e.g., using the MESSAGEMAX T7 ARCA-capped message transcription kit or the INCOGNITO T7 ARCA 5′C- and Ψ-RNA transcription kit, CELLSCRIPT, Inc., Madison, Wis., USA); or (ii) post-transcriptionally by incubating in vitro-transcribed ssRNA molecules with a capping enzyme system comprising RNA guanyltransferase under conditions wherein the in vitro-transcribed ssRNA molecules are 5′-capped, including wherein the capping enzyme system results in methylation of the 2′ hydroxyl of the ribose in the 5′ penultimate nucleotide (e.g., using T7 mSCRIPT standard mRNA production system, or using a separate in vitro transcription system, such as the T7-SCRIBE standard RNA IVT kit, the INCOGNITO T7 Ψ-RNA transcription kit, or the INCOGNITO T7 5mC- and Ψ-RNA transcription kit to obtain ssRNA, and the SCRIPTCAP m7G capping system to obtain cap0 RNA (all from CELLSCRIPT, Inc.); in some embodiments, the capping enzyme system further results in methylation of the 2′ hydroxyl of the ribose in the 5′ penultimate nucleotide to generate cap1 RNA, and the method further comprises: incubating with RNA 2′-O-methyltransferase (e.g., using the SCRIPTCAP 2′-O-methyltransferase kit, CELLSCRIPT, Inc.).

Methylation:

Article Title: Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect
Article Snippet: A 1671-basepair insert, as shown in FIG. 1, was cut from the plasmid backbone with ClaI and then single-stranded RNA (ssRNA) was generated by in vitro transcription of each DNA strand (FIG. 1) in two separate reactions using either a T7-ScribeTM Standard RNA IVT Kit (CELLSCRIPT, INC., Madison, Wis., USA) or an AmpliScribeTM T3 High Yield transcription Kit (epicentre, WI), respectively.

Article Title: An RNA vaccine against adrenomedullin reduces angiogenesis and tumor burden in a syngeneic metastatic melanoma mouse model.
Article Snippet: 2.4 In vitro transcription, capping and characterization The therapeutic mRNA was synthesized by in vitro transcription (IVT) using T7-Scribe Standard RNA IVT Kit (CellScript, Madison, WI, USA) to produce standard/non-modified mRNA.

Article Title: An RNA vaccine against adrenomedullin reduces angiogenesis and tumor burden in a syngeneic metastatic melanoma mouse model
Article Snippet: The therapeutic mRNA was synthesized by in vitro transcription (IVT) using T7-ScribeTM Standard RNA IVT Kit (CellScript, Madison, WI, USA) to produce standard/non-modified mRNA.

Article Title: Methods of assessing nuclease cleavage
Article Snippet: T Cell—Gene 1/Gene 2 S. pyogenes guide RNAs targeting the Gene 1 and Gene 2 loci were generated by in vitro transcription of a PCR product using the T7-ScribeTM Standard RNA IVT Kit (CELLSCRIPT) following the manufacturer's protocol.

Article Title: Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect
Article Snippet: Each sense or antisense ssRNA strand was synthesized separately by in vitro transcription of a linear luc2 DNA template using either 17 RNA polymerase or T3 RNA polymerase, such as with a commercially available INCOGNITOTM T7 Ψ-RNA transcription kit (CELLSCRIPT, INC., Madison, WI, USA) for making GAψC RNA, or a T7-FLASHSCRIBETM transcription kit or a T7-SCRIBETM standard RNA IVT kit for making GAUC RNA (CELLSCRIPT), or similar home-brew kits containing T3 RNA polymerase.

Article Title: Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect
Article Snippet: In some of these embodiments, the one or more in vitro-synthesized ssRNA molecules that exhibit the 5′ cap were synthesized prior to their use for said treating: (i) co-transcriptionally by incorporation of a cap analog (e.g., an anti-reverse cap analog or ARCA) during in vitro transcription of (e.g., using the MESSAGEMAX T7 ARCA-capped message transcription kit or the INCOGNITO T7 ARCA 5′C- and Ψ-RNA transcription kit, CELLSCRIPT, Inc., Madison, Wis., USA); or (ii) post-transcriptionally by incubating in vitro-transcribed ssRNA molecules with a capping enzyme system comprising RNA guanyltransferase under conditions wherein the in vitro-transcribed ssRNA molecules are 5′-capped, including wherein the capping enzyme system results in methylation of the 2′ hydroxyl of the ribose in the 5′ penultimate nucleotide (e.g., using T7 mSCRIPT standard mRNA production system, or using a separate in vitro transcription system, such as the T7-SCRIBE standard RNA IVT kit, the INCOGNITO T7 Ψ-RNA transcription kit, or the INCOGNITO T7 5mC- and Ψ-RNA transcription kit to obtain ssRNA, and the SCRIPTCAP m7G capping system to obtain cap0 RNA (all from CELLSCRIPT, Inc.); in some embodiments, the capping enzyme system further results in methylation of the 2′ hydroxyl of the ribose in the 5′ penultimate nucleotide to generate cap1 RNA, and the method further comprises: incubating with RNA 2′-O-methyltransferase (e.g., using the SCRIPTCAP 2′-O-methyltransferase kit, CELLSCRIPT, Inc.).



Similar Products

90
Cellscript Inc t7-scribetm standard rna ivt kit
T7 Scribetm Standard Rna Ivt Kit, supplied by Cellscript Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t7-scribetm+standard+rna+ivt+kit/t7+scribe+standard+rna+ivt+kit/pm40539045-86-18-23
Average 90 stars, based on 1 article reviews
t7-scribetm standard rna ivt kit - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results